Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel TcVO(III) N2S2 complexes: interconversion by redox reaction

S Oya1, M P Kung, D Frederick

  • 1Department of Radiology, University of Pennsylvania, Philadelphia 19104, USA.

Nuclear Medicine and Biology
|July 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A requirement for cell elongation protein RodZ and cell division proteins FtsN and DedD to maintain the small rod morphology of Escherichia coli at growth temperatures near 8°C.

The Journal of general and applied microbiology·2016
Same author

Differential gene expression profile of CD4+/CD8+ T cells in patients with hepatitis C virus and/or human immunodeficiency virus infection.

Hong Kong medical journal = Xianggang yi xue za zhi·2016
Same author

Decreased expression of H3K27me3 in human ovarian carcinomas correlates with more aggressive tumor behavior and poor patient survival.

Neoplasma·2015
Same author

MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of β-catenin signaling.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2.

Oncogene·2014
Same author

HGFK1 inhibits bone metastasis in breast cancer through the TAK1/p38 MAPK signaling pathway.

Cancer gene therapy·2012
Same journal

Electroless semi-automatic synthesis of <sup>225</sup>Ac-labeled PSMA-derivatives for clinical application and evaluation of rechelation capability.

Nuclear medicine and biology·2026
Same journal

Preparation of electroplated zinc-68 targets for gallium-68 cyclotron production using recovered zinc-68.

Nuclear medicine and biology·2026
Same journal

Enhanced pre-therapy dosimetry for SSTR PET: A head-to-head preclinical assessment of [<sup>89</sup>Zr]Zr-DFO-TOC and [<sup>89</sup>Zr]Zr-DFO-TATE.

Nuclear medicine and biology·2026
Same journal

Pharmacokinetics and dosimetry of radiolabeled FAP-targeting single-domain antibody 4AH29 in Göttingen minipigs.

Nuclear medicine and biology·2026
Same journal

Comparative intra-articular retention of [<sup>177</sup>Lu]Lu-MAA and <sup>90</sup>Y resin in a rat knee model.

Nuclear medicine and biology·2026
Same journal

Evaluating the tumour detection efficacy of [<sup>18</sup>F]Fluorthanatrace positron emission tomography in a metastatic lung cancer animal model.

Nuclear medicine and biology·2026
See all related articles

A novel bisaminoethanethiol (BAT) ligand was synthesized to create versatile technetium-99m (Tc-99m) complexes. These stable Tc-99m complexes, in both reduced and oxidized states, demonstrated moderate brain uptake in rats, suggesting potential for derivative development.

Area of Science:

  • Radiochemistry
  • Inorganic Chemistry
  • Nuclear Medicine

Background:

  • Developing versatile ligands is crucial for expanding the applications of technetium-99m (Tc-99m) radiopharmaceuticals.
  • Tc-99m complexes with TcVO centers require adaptable ligand systems for diverse imaging applications.

Purpose of the Study:

  • To synthesize a new bisaminoethanethiol (BAT) ligand for complexing a TcVO center.
  • To evaluate the stability and interconversion of reduced and oxidized Tc-99m complexes formed with the novel BAT ligand.
  • To assess the in vivo biodistribution, specifically brain uptake, of these Tc-99m complexes in a rat model.

Main Methods:

  • Synthesis of a novel bisaminoethanethiol (BAT) ligand (ligand 7).
  • Formation and characterization of neutral, stable Tc-99m complexes in both reduced and oxidized states.

Related Experiment Videos

  • In vivo biodistribution studies in rats, measuring organ uptake at 30 minutes post-injection.

    • Main Results:

    • A new BAT ligand was successfully synthesized.
    • Neutral and stable Tc-99m complexes ([99mTc]7) were formed, existing in both reduced and interconvertible oxidized forms.
    • Both forms exhibited moderate brain uptake in rats (0.17% and 0.1% dose/organ for reduced and oxidized, respectively).

    Conclusions:

    • The novel BAT ligand facilitates the creation of versatile and stable Tc-99m complexes.
    • The interconversion between reduced and oxidized states offers flexibility in complex design.
    • These findings support the potential for developing various derivatives for further nuclear medicine studies.